| Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties D Zucker, D Marcus, Y Barenholz, A Goldblum Journal of controlled release 139 (1), 73-80, 2009 | 418 | 2009 |
| Carbon nanotubes-liposomes conjugate as a platform for drug delivery into cells F Karchemski, D Zucker, Y Barenholz, O Regev Journal of Controlled Release 160 (2), 339–345, 2012 | 109 | 2012 |
| Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy D Zucker, A Andrianov, A Steiner, U Raviv, Y Barenholz Journal of Controlled Release 160 (2), 281–289, 2011 | 103 | 2011 |
| Optimization of vincristine–topotecan combination—Paving the way for improved chemotherapy regimens by nanoliposomes D Zucker, Y Barenholz Journal of controlled release 146 (3), 326-333, 2010 | 90 | 2010 |
| Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines et al. Thomas C. B. Klauber, Janne M. Laursen, Daniel Zucker Acta Biomaterialia 53, 367–377, 2017 | 45 | 2017 |
| Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist PT Johansen, D Zucker, L Parhamifar, H Pourhassan, DV Madsen, ... Expert opinion on drug delivery 12 (7), 1045-58, 2015 | 19 | 2015 |
| Can carbon nanotube–liposome conjugation address the issues associated with carbon nanotubes in drug delivery? O Regev, Y Barenholz, S Peretz, D Zucker, Y Bavli-Felsen Future medicinal chemistry 5 (5), 503, 2013 | 11 | 2013 |
| Liposomes comprising amphipathic drugs and method for their preparation Y Barenholz, D Zucker US Patent App. 13/576,570, 2013 | 9 | 2013 |
| Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes SS Jensen, PT Johansen, D Zucker, J Henriksen, T Andresen, A Barberis, ... Journal for ImmunoTherapy of Cancer 1, 1-1, 2013 | 1 | 2013 |
| Formulation for administration of RNA et al. Daniel Zucker, Heinrich Haas, Anne Schlegel EP Patent App. PCT/EP2016/066,930, 2018 | | 2018 |
| Cationic lipid vehicles for delivery of TLR7 agonists for specific targeting of human CD14+ monocytes in whole blood D Zucker, S Jensen, T Andresen, R Maj, A Barberis EP Patent App. PCT/EP2013/069,065, 2015 | | 2015 |
| Targeting monocytes using a novel liposome based delivery system S Jensen, M Gad, H Pourhassan, D Zucker, P Johansen, J Wern, ... Scandinavian Journal of Immunology 77 (4), 330, 2013 | | 2013 |
| Nano-PEGylated Liposomes Co-remotely Loaded with Topotecan and Vincristine for Treatment of Relevant Cancers D Zucker Hebrew University, 2010 | | 2010 |
yechezkel barenholzhebrew university of jerusalem在 ekmd.huji.ac.il 的电子邮件经过验证
